Fulfilling the Boehringer Ingelheim Jida (Chengdu) Rehabilitation Medical Center for the first time at the Expo

SHANGHAI, Nov.
6, 2022 /PRNewswire/ -- Boehringer Ingelheim Buda (Chengdu) Rehabilitation Medical Center was officially unveiled
at the 5th China International Import Expo.
The rehabilitation medical center is jointly invested by Boehringer Ingelheim and the People's Government of Wenjiang District of Chengdu, and is the first rehabilitation medical center
invested by Boehringer Ingelheim in the western region of China.

This is the first result
of the Expo after Boehringer Ingelheim and the Wenjiang District Government of Chengdu signed the investment cooperation agreement of the Chengdu rehabilitation project at the 4th CIIE.
As a representative case of the spillover effect of the Expo selected as the "Expo Exhibition Hall for the 20 Years of China's WTO Accession" last year, the Chengdu project of Jida Rehabilitation was highlighted in the newly established "Exhibitors Become Investors" exhibition area at this Expo, comprehensively displaying the spillover effect of "exhibits turning into commodities and exhibitors becoming investors", and reviewing the "co-evolution"
of Jida Rehabilitation and CIIE in the past five years.

Innovative holistic solutions to address stroke challenges

Stroke, commonly known as "cerebral stroke", is the primary cause of death and disability among adults in China, with the characteristics of high morbidity, high disability rate, high mortality rate, high recurrence rate and high economic burden
.
According to the latest China Stroke Report 2020, in 2019 alone, there were 3.
94 million new strokes in China, 2.
19 million stroke deaths, and 28.
76 million stroke patients, and China is facing the world's largest stroke challenge
.

The prevention and treatment of stroke requires the joint efforts
of the whole society.
The "Healthy China 2030" planning outline clearly proposes to prevent and treat major diseases such as stroke, and improve the treatment-rehabilitation-long-term care service chain
.

As a leader in stroke disease, Boehringer Ingelheim has international expertise and experience
in stroke prevention and treatment.
The company integrates its own advantages and experience, and works with relevant partners to launch an innovative "stroke overall solution" with patients as the center, covering seven modules
: prevention, disease education, testing, first aid, diagnosis, treatment and rehabilitation.
At the same time, with the launch of the Chengdu project of Jida Rehabilitation, we hope to better bring the German advanced stroke rehabilitation concept to China and meet the unmet needs
in the field of stroke rehabilitation in China.

The Chengdu rehabilitation project includes the offline Chengdu rehabilitation medical center and online Internet hospital
.
Located in Chengdu Wenjiang District Medical City, Chengdu Rehabilitation Medical Center, the offline physical rehabilitation center has a planned area of about 13,500 square meters, of which the rehabilitation treatment area is about 5,000 square meters, and 150 beds are planned to be opened.

With neurological rehabilitation as the core and stroke rehabilitation as the feature, the rehabilitation center introduces German standard rehabilitation treatment and the world's top rehabilitation equipment to China, and combines it with Boehringer Ingelheim's stroke full-course solution to provide patients with personalized, standardized and professional "German gold standard" health management services
.
The Rehabilitation Internet Hospital intends to become an extension of the offline physical rehabilitation center business, which will provide German standard digital home rehabilitation training support and guidance
for mild and moderate stroke patients.
The main functional modules include personalized diagnosis and treatment, system planning, daily training, motion capture, rehabilitation consultation, patient education, and mental health support
.

Jida Rehabilitation settled in Chengdu to help the health construction of the western region

As a rehabilitation brand of Boehringer Ingelheim, Gida Rehabilitation is committed to bringing the century-old German neurorehabilitation concept and advanced rehabilitation model to countries and regions
around the world that urgently need stroke rehabilitation.
Help people with stroke overcome dysfunction, rebuild their independence in daily life and their ability to adapt to society, so that they can better return to the life, work and society they love
.
Since 2018, Jida Rehabilitation and Shanghai International Medical Center (SIMC) have jointly established the Department of Rehabilitation Medicine to provide patients with rehabilitation treatment programs
in the fields of neurology and orthopedics.
As of October 2022, it has provided the world's leading rehabilitation consultation and diagnosis services to more than 1,300 patients
.

In the past five years, with the help of the spillover effect of Jinbo, Boehringer Ingelheim has integrated its own advantages and global advanced rehabilitation experience, and continuously demonstrated the innovative "Total Stroke Solution" and the Jida rehabilitation brand to the public with the help of the Jinbo platform, which has won the attention and attention
of many parties.
Today, Boehringer Ingelheim Chengdu Rehabilitation Project debuted, truly realizing the transformation
from "exhibitor to investor".

Dr.
Dong Bowen, General Manager of Boehringer Ingelheim Chinese Pharmaceuticals, said that with the completion of the Chengdu Rehabilitation Medical Center, we hope to radiate the concept of stroke rehabilitation of international standards to the entire western region of China, provide patients with German gold standard stroke rehabilitation services, and help improve the level of stroke rehabilitation in
Sichuan and even the entire western part of China.
The smooth landing of the project is inseparable from the policy, resources and supporting support of Chengdu Wenjiang District, which provides a strong guarantee
for the implementation and construction of the project.
Chengdu is the most important national central city in western China, an important economic center and science and technology innovation center in the country, and an important node city
of the "Belt and Road" and the Yangtze River Economic Belt.
We also hope to build long-term close cooperation with more partners to bring Jida rehabilitation to other cities and regions in China to build an all-round stroke management ecosystem
.
Make unremitting efforts to build a sound stroke prevention system and build a healthy city for Chinese cities, and help realize "Healthy China 2030
".

Ma Liehong, deputy secretary of the Wenjiang District Party Committee and mayor of Wenjiang District, Chengdu, said that the Chengdu project, as one of the major projects of the industrial construction circle and strong chain in Wenjiang District of Chengdu in 2022, has been highly valued
by the Wenjiang District Government and the park.
It is hoped that with the implementation of the Chengdu project of Jida Rehabilitation, it will contribute to the stroke management cause in Sichuan and even the entire western part of China, and help Sichuan build a healthy aging society and improve the health level of
the elderly.